# A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy

> **NCT05081518** · PHASE1 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 1 (actual)

## Conditions studied

- Focal Epilepsy

## Interventions

- **DRUG:** Lu AG06466
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05081518
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-29
- **Primary completion:** 2022-04-14
- **Final completion:** 2022-04-14
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The study was terminated due to enrolment challenges
- **Last updated:** 2022-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05081518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05081518, "A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05081518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*